Loading...
Loading...
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on HZNP's earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Horizon Pharma could be a solid choice for investors.
Current Quarter Estimates for HZNP
In the past 30 days, 1 estimate has gone higher for Horizon Pharma while no estimate moved lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 8 cents a share 30 days ago, to a profit of 4 cents today.
Current Year Estimates for HZNP
Meanwhile, Horizon Pharma's current year figures are also looking quite promising, with 2 estimates moving higher in the past month, compared to no estimate moving lower. The consensus estimate trend has also seen a boost for this time frame, increasing from 10 cents per share 30 days ago to 41 cents per share today, an increase of 310%.
Bottom Line
The stock has also started to move higher lately, adding 25.23% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
HORIZON PHARMA HZNP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in